190 related articles for article (PubMed ID: 20235120)
1. Characterization of MRI contrast agent-loaded polymeric nanocapsules as versatile vehicle for targeted imaging.
Sharma S; Paiphansiri U; Hombach V; Mailänder V; Zimmermann O; Landfester K; Rasche V
Contrast Media Mol Imaging; 2010; 5(2):59-69. PubMed ID: 20235120
[TBL] [Abstract][Full Text] [Related]
2. Tailor-made nanocontainers for combined magnetic-field-induced release and MRI.
Bannwarth MB; Ebert S; Lauck M; Ziener U; Tomcin S; Jakob G; Münnemann K; Mailänder V; Musyanovych A; Landfester K
Macromol Biosci; 2014 Sep; 14(9):1205-14. PubMed ID: 24811570
[TBL] [Abstract][Full Text] [Related]
3. Highly Loaded Semipermeable Nanocapsules for Magnetic Resonance Imaging.
Schlegel I; Renz P; Simon J; Lieberwirth I; Pektor S; Bausbacher N; Miederer M; Mailänder V; Muñoz-Espí R; Crespy D; Landfester K
Macromol Biosci; 2018 Apr; 18(4):e1700387. PubMed ID: 29392837
[TBL] [Abstract][Full Text] [Related]
4. Nano assembly and encapsulation; a versatile platform for slowing the rotation of polyanionic Gd(3+) -based MRI contrast agents.
Farashishiko A; Chacón KN; Blackburn NJ; Woods M
Contrast Media Mol Imaging; 2016; 11(2):154-9. PubMed ID: 26708733
[TBL] [Abstract][Full Text] [Related]
5. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
Rowe MD; Chang CC; Thamm DH; Kraft SL; Harmon JF; Vogt AP; Sumerlin BS; Boyes SG
Langmuir; 2009 Aug; 25(16):9487-99. PubMed ID: 19422256
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Microenvironment Relaxivity-Changeable Gd-Loaded Poly(L-lysine)/Carboxymethyl Chitosan Nanoparticles as Cancer-Recognizable Magnetic Resonance Imaging Contrast Agents.
Jiang D; Zhang X; Yu D; Xiao Y; Wang T; Su Z; Liu Y; Zhang N
J Biomed Nanotechnol; 2017 Mar; 13(3):243-54. PubMed ID: 29381026
[TBL] [Abstract][Full Text] [Related]
7. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
Riyahi-Alam N; Behrouzkia Z; Seifalian A; Haghgoo Jahromi S
Biol Trace Elem Res; 2010 Dec; 137(3):324-34. PubMed ID: 20049554
[TBL] [Abstract][Full Text] [Related]
8. Cleavable β-cyclodextrin nanocapsules incorporating Gd(III)-chelates as bioresponsive MRI probes.
Martinelli J; Fekete M; Tei L; Botta M
Chem Commun (Camb); 2011 Mar; 47(11):3144-6. PubMed ID: 21270985
[TBL] [Abstract][Full Text] [Related]
9. Design and Control of Nanoconfinement to Achieve Magnetic Resonance Contrast Agents with High Relaxivity.
Malzahn K; Ebert S; Schlegel I; Neudert O; Wagner M; Schütz G; Ide A; Roohi F; Münnemann K; Crespy D; Landfester K
Adv Healthc Mater; 2016 Mar; 5(5):567-74. PubMed ID: 26696569
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
[TBL] [Abstract][Full Text] [Related]
11. Trifunctional Polymeric Nanocomposites Incorporated with Fe₃O₄/Iodine-Containing Rare Earth Complex for Computed X-ray Tomography, Magnetic Resonance, and Optical Imaging.
Wang X; Tu M; Yan K; Li P; Pang L; Gong Y; Li Q; Liu R; Xu Z; Xu H; Chu PK
ACS Appl Mater Interfaces; 2015 Nov; 7(44):24523-32. PubMed ID: 26484385
[TBL] [Abstract][Full Text] [Related]
12. How morphology influences relaxivity - comparative study of superparamagnetic iron oxide-polymer hybrid nanostructures.
Ebert S; Bannwarth MB; Musyanovych A; Landfester K; Münnemann K
Contrast Media Mol Imaging; 2015; 10(6):456-64. PubMed ID: 26153149
[TBL] [Abstract][Full Text] [Related]
13. Effective encapsulation of a new cationic gadolinium chelate into apoferritin and its evaluation as an MRI contrast agent.
Makino A; Harada H; Okada T; Kimura H; Amano H; Saji H; Hiraoka M; Kimura S
Nanomedicine; 2011 Oct; 7(5):638-46. PubMed ID: 21333752
[TBL] [Abstract][Full Text] [Related]
14. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Characterization, and Magnetic Resonance Evaluation of Polyglycerol-Functionalized Detonation Nanodiamond Conjugated with Gadolinium(III) Complex.
Zhao L; Shiino A; Qin H; Kimura T; Komatsu N
J Nanosci Nanotechnol; 2015 Feb; 15(2):1076-82. PubMed ID: 26353615
[TBL] [Abstract][Full Text] [Related]
16. "Two-in-one" fabrication of Fe3O4/MePEG-PLA composite nanocapsules as a potential ultrasonic/MRI dual contrast agent.
Xu B; Dou H; Tao K; Sun K; Ding J; Shi W; Guo X; Li J; Zhang D; Sun K
Langmuir; 2011 Oct; 27(19):12134-42. PubMed ID: 21863846
[TBL] [Abstract][Full Text] [Related]
17. RGD decoration of PEGylated polyester nanocapsules of perfluorooctyl bromide for tumor imaging: influence of pre or post-functionalization on capsule morphology.
Diou O; Fattal E; Delplace V; Mackiewicz N; Nicolas J; Mériaux S; Valette J; Robic C; Tsapis N
Eur J Pharm Biopharm; 2014 May; 87(1):170-7. PubMed ID: 24333400
[TBL] [Abstract][Full Text] [Related]
18. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
[TBL] [Abstract][Full Text] [Related]
19. An extracellular MRI polymeric contrast agent that degrades at physiological pH.
Schopf E; Sankaranarayanan J; Chan M; Mattrey R; Almutairi A
Mol Pharm; 2012 Jul; 9(7):1911-8. PubMed ID: 22657107
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a tartaric acid derived polymeric MRI contrast agent to a small molecule model chelate.
Lucas RL; Benjamin M; Reineke TM
Bioconjug Chem; 2008 Jan; 19(1):24-7. PubMed ID: 18092744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
